Closed
SectorHealthcare
35.34 4.59
24h
Min
33.5
Max
35.38
Income | 131K -133M |
---|---|
Sales | 25M 165M |
EPS | -1.39 |
Profit margin | -80.9 |
Employees | 1,294 |
EBITDA | -59K -109M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +177.96% upside |
Next Earnings | 1 maj 2025 |
---|
Market Cap | -44M 3.5B |
---|---|
Previous open | 30.75 |
Previous close | 35.34 |
By Acuity
45%
55%
165 / 386 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 94.06 USD 177.96%
High 140 USD
Low 47 USD
Based on 17 Wall Street analysts offering 12 month price targets forUltragenyx Pharmaceutical Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$